{"product_id":"klow-blend","title":"KLOW Blend","description":"\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cp dir=\"auto\" style=\"white-space: pre-wrap;\"\u003e\u003cstrong\u003eKLOW Blend\u003c\/strong\u003e (also known as \u003cstrong\u003eKlow Stack\u003c\/strong\u003e or \u003cstrong\u003eRadiance Recovery Blend\u003c\/strong\u003e) is a \u003cstrong\u003esynthetic multi-peptide formulation\u003c\/strong\u003e combining \u003cstrong\u003eBPC-157\u003c\/strong\u003e, \u003cstrong\u003eTB-500\u003c\/strong\u003e (Thymosin Beta-4), \u003cstrong\u003eKPV\u003c\/strong\u003e, and \u003cstrong\u003eGHK-Cu\u003c\/strong\u003e in a single lyophilized vial (commonly totaling 80 mg, with typical ratios such as BPC-157 10 mg, TB-500 10 mg, KPV 10 mg, GHK-Cu 50 mg). This research blend has garnered significant attention in preclinical regenerative studies for its synergistic potential to address tissue repair, inflammation resolution, immune modulation, and extracellular matrix remodeling through complementary pathways. It builds on simpler blends like Wolverine (BPC-157 + TB-500) by incorporating KPV for enhanced anti-inflammatory effects and GHK-Cu for collagen synthesis and dermal\/tissue rejuvenation. Researchers employ KLOW Blend in laboratory and animal models to investigate multi-target regenerative mechanisms, particularly in injury recovery, chronic inflammation, wound healing, and age-related tissue decline. As a research-grade compound, KLOW Blend is intended exclusively for in vitro and animal studies. Scientists value its broad-spectrum approach, combining cytoprotective, angiogenic, actin-regulatory, and copper-mediated signaling for comprehensive tissue restoration research.\u003c\/p\u003e\n\u003ch3 dir=\"auto\"\u003eKey Research Applications\u003c\/h3\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eComprehensive Tissue and Musculoskeletal Regeneration\u003c\/strong\u003e — Preclinical models show the blend accelerates repair of muscles, tendons, ligaments, skin, and connective tissues. BPC-157 and TB-500 drive angiogenesis and cell migration, while GHK-Cu supports collagen deposition and matrix remodeling, often yielding enhanced biomechanical recovery in injury and overuse paradigms.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAnti-Inflammatory and Immune Modulation\u003c\/strong\u003e — KPV potently suppresses pro-inflammatory cytokines (e.g., TNF-α, IL-6) and NF-κB signaling, complementing the cytoprotective and resolution-promoting actions of the other components. Studies explore efficacy in models of chronic inflammation, autoimmune-like conditions, gastrointestinal insults, and systemic inflammatory states.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWound Healing and Dermal Repair\u003c\/strong\u003e — The combination promotes re-epithelialization, granulation tissue formation, reduced scarring, and improved collagen organization. GHK-Cu's role in extracellular matrix synthesis synergizes with TB-500's cell motility and BPC-157's growth factor modulation, making it a focus in cutaneous, surgical, and chronic wound models.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSystemic Recovery and Anti-Aging Effects\u003c\/strong\u003e — Investigations highlight benefits in metabolic support, oxidative stress reduction, mitochondrial function preservation, and overall tissue resilience. The blend is studied for potential in age-related decline, post-exercise recovery, and multi-organ protection (e.g., gut, skin, musculoskeletal).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSynergistic Multi-Pathway Mechanisms\u003c\/strong\u003e — Research examines how the four peptides interact to amplify regenerative outcomes beyond individual administration, including enhanced VEGF pathways, actin dynamics, copper-dependent enzyme activity, and melanocortin-mediated inflammation control.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 dir=\"auto\"\u003eTechnical Specifications\u003c\/h3\u003e\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eComposition\u003c\/strong\u003e: Blend of BPC-157 (C₆₂H₉₈N₁₆O₂₂; MW 1419.5 g\/mol), TB-500 (C₂₁₂H₃₅₀N₅₆O₇₈S; MW 4963.5 g\/mol), KPV (C₁₆H₃₀N₄O₄; MW 342.43 g\/mol), GHK-Cu (C₁₄H₂₂CuN₆O₄; MW 401.9 g\/mol).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMolecular Weight\u003c\/strong\u003e: Composite (varies by exact ratio; approximately 6,000–7,000 g\/mol for standard formulations).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSequences\u003c\/strong\u003e:\n\u003cul dir=\"auto\"\u003e\n\u003cli\u003eBPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val\u003c\/li\u003e\n\u003cli\u003eTB-500: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser\u003c\/li\u003e\n\u003cli\u003eKPV: Lys-Pro-Val\u003c\/li\u003e\n\u003cli\u003eGHK-Cu: Gly-His-Lys (complexed with Cu²⁺)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e","brand":"Omni Peptides","offers":[{"title":"Default Title","offer_id":50432797409527,"sku":"KLOW80","price":1150.0,"currency_code":"AED","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0918\/6777\/5223\/files\/klow_80mg.png?v=1771307398","url":"https:\/\/dubaipeptides.ae\/products\/klow-blend","provider":"Dubai Peptides","version":"1.0","type":"link"}